Cerubidine

Active Ingredient(s): Daunorubicin
FDA Approved: * December 19, 1979
Pharm Company: * WYETH AYERST
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Cerubidine Overview

Daunorubicin, also known as daunomycin, is a chemotherapy medication used to treat cancer.[1] Specifically it is used for acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and Kaposi's sarcoma.[1] It is used by injection into a vein.[1] A liposomal formulation known as liposomal daunorubicin also exists.[1] Common side effects include hair loss, vomiting, bone marrow suppression, ...

Read more Cerubidine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Daunorubicin

Recent Cerubidine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Daunorubicin
  • Injection: 20mg, 20mg/vial, 50mg, 5mg, 5mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Daunorubicin or a similar ingredient: (5 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 10 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA